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The major acceptors of sialic acid on the surface of
metacyclic trypomastigotes, which are the infective
forms of Trypanosoma cruzi found in the insect vector,
are mucin-like glycoproteins linked to the parasite
membrane via glycosylphosphatidylinositol anchors.
Here we have compared the lipid and the carbohydrate
structure of the glycosylphosphatidylinositol anchors
and theO-linked oligosaccharides of themucins isolated
from metacyclic trypomastigotes and noninfective epi-
mastigote forms obtained in culture. The single differ-
ence found was in the lipid structure. While the phos-
phatidylinositol moiety of the epimastigote mucins
contains mainly 1-O-hexadecyl-2-O-hexadecanoylphos-
phatidylinositol, the phosphatidylinositol moiety of the
metacyclic trypomastigote mucins contains mostly
(;70%) inositol phosphoceramides, consisting of a C18:0
sphinganine long chain base and mainly C24:0 and C16:0
fatty acids. The remaining 30% of the metacyclic phos-
phatidylinositol moieties are the same alkylacylphos-
phatidylinositol species found in epimastigotes. In con-
trast, the glycosylphosphatidylinositol glycan cores of
both molecules are very similar, mainly Mana1–
2Mana1–2Mana1–6Mana1–4GlcN. The glycans are sub-
stituted at the GlcN residue and at the third aMan distal
to the GlcN residue by ethanolamine phosphate or
2-aminoethylphosphonate groups. The structures of the
desialylatedO-linked oligosaccharides of the metacyclic
trypomastigote mucin-like molecules, released by
b-elimination with concomitant reduction, are identical
to the structures reported for the epimastigote mucins
(Previato, J. O., Jones, C., Gonçalves, L. P. B., Wait, R.,
Travassos, L. R., and Mendoça-Previato, L. (1994) Bio-
chem. J. 301, 151–159). In addition, a significant amount
of nonsubstituted N-acetylglucosaminitol was released
from the mucins of both forms of the parasite. Taken
together, these results indicate that when epimastigotes
transform into infectivemetacyclic trypomastigotes, the
phosphatidylinositolmoietyoftheglycosylphosphatidyl-
inositol anchor of the major acceptor of sialic acid is
modified, while the glycosylphosphatidylinositol an-
chor and O-linked sugar chains remain essentially
unchanged.
Trypanosoma cruzi, the protozoan parasite that causes Cha-
gas’ disease in humans, has a complex life cycle alternating
between the insect vector and the mammalian host. In the
vector, it multiplies as noninfective epimastigotes that migrate
to the hindgut and differentiate into infective metacyclic try-
pomastigotes. During the insect blood meal, the metacyclic
trypomastigotes are deposited with the feces and urine near a
skin wound, initiating the natural infection.
T. cruzi is unable to synthesize sialic acids (SA),1 but it
expresses a unique trans-sialidase (TS), which transfers a2–3-
linked SA from host glycoproteins and glycolipids to acceptors
containing terminal b-galactosyl residues present on the par-
asite surface (reviewed in Refs. 1–4). Several studies charac-
terizing the nature and structure of the SA acceptors have been
published. These acceptors are abundant on the parasite sur-
face and were first described as major surface glycoproteins of
epimastigotes by Alves and Colli (5), who called them bands A,
B, and C. Subsequently, a similar cell surface glycoprotein
complex, called GP24, GP31, and GP37 was described by Fer-
guson et al. (6), and Previato et al. (7) first described a 43-kDa
SA acceptor. More recently, they have been called 38/43 glyco-
conjugates (8), and the so called epimastigote lipophosphogly-
can-like molecule could belong to the same family of molecules
(9). In metacyclic trypomastigote forms, the SA acceptors were
reported originally as the 35/50-kDa antigens (10, 11) that were
subsequently defined as mucin-like glycoproteins (12). In the
trypomastigote forms found in mammals, the SA acceptors
were described as a group of molecules that share the stage-
specific epitope 3 (Ssp-3) (13), an epitope dependent on parasite
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sialylation (14), and were also identified as mucin-like mole-
cules that appear larger than the epimastigote and metacyclic
mucins on SDS-polyacrylamide gel electrophoresis (15, 16).
These trypomastigote mucins also contain some terminal
a-galactosyl residues (16). In summary, these mucin-like mol-
ecules are glycoproteins rich in threonine and serine that are
linked to the parasite membrane via a glycosylphosphatidyl-
inositol (GPI) anchor and that contain novel O-linked oligosac-
charides. The O-linked oligosaccharides are attached to the
protein via GlcNAc residues and act as SA acceptor sites for the
parasite TS. The chemical structure of O-linked oligosaccha-
rides of epimastigote mucins of G (8) and Y (17) strains have
recently been elucidated. They are quite similar but differ in
their average size and in some of the Gal linkages. The glycan
structure of the GPI anchor of the epimastigote mucin (Y
strain) has also been reported (17).
Several lines of evidence suggest that the 35/50-kDa mucins
of metacyclic-trypomastigotes are involved in host cell inva-
sion. Monoclonal antibodies directed against the mucin, and
the purified molecule itself, are able to inhibit parasite entry
(10, 18), and the 35/50-kDa antigens are capped and locally
released during invasion (12). Epimastigotes are unable to
enter mammalian cells but express large amounts of mucins
with similar size recognized by the same monoclonal antibod-
ies. Therefore, we decided to investigate possible subtle struc-
tural differences between the mucins of these two stages. We
found that, after differentiation of epimastigotes into metacy-
clic forms, the lipid portion is modified, while the oligosaccha-
ride chains and the glycan structure of the GPI are conserved.
This lipid change might correlate with the increased infectivity
of metacyclic forms and the ability of the parasite to shed the
mucins upon invasion of the host cell (12).
MATERIALS AND METHODS
Parasites—Epimastigotes of T. cruzi strain G (19) were grown at
28 °C in liver-infusion tryptose medium (20) containing 10% fetal bo-
vine serum. Metacyclic trypomastigotes were purified from cultures at
stationary phase by passage through a diethylaminoethyl cellulose
column, as described in Ref. 19. The purity of the metacyclic trypomas-
tigote preparations were estimated by morphology and/or by comple-
ment-mediated lysis assay using normal human sera.
Purification of Mucins—Mucins from epimastigotes and metacyclic
trypomastigotes were extracted as described for the lipophosphoglycan
of Leishmania donovani (21). Briefly, parasites (;7 3 1010 epimastig-
otes and ;8 3 1010 metacyclic trypomastigotes) were freeze-dried and
placed in a sonicating water bath for 10 min with 50 ml of chloroform/
methanol/water (1:2:0.8, by volume). After centrifugation (2,000 3 g, 5
min) the insoluble material was re-extracted twice more, as described
above, and the final insoluble pellet was used as a source of delipidated
parasites. The pooled chloroform/methanol/water soluble fractions were
evaporated under nitrogen, and the residue was extracted with 50 ml of
butan-1-ol/water (2:1, by volume). The butan-1-ol phase, containing the
lipid fraction (F1) was collected, and the aqueous phase (F2) was
washed twice with 25 ml of water-saturated butan-1-ol and concen-
trated. The delipidated parasites were extracted by sonication (three
times) with 25 ml of 9% butanol in water. The soluble material was
pooled, concentrated, and freeze-dried to produce a polar fraction (F3).
Most of the mucins from epimastigotes were recovered in F2, while
mucins of metacyclic trypomastigotes were recovered in the F3 fraction.
The mucins were resuspended in 0.5 ml of 0.1 M ammonium acetate in
5% propan-1-ol (v/v) (buffer A) and fractionated on an octyl-Sepharose
column (10 3 0.5 cm), previously equilibrated in buffer A. The column
was washed with 15 ml of buffer A and eluted with a linear gradient
over 100 ml at a flow rate of 12 ml/h, starting with buffer A and ending
with 60% (v/v) propan-1-ol in water. Fractions of 1 ml were assayed for
reactivity with the monoclonal antibody 10D8 (10) by using a chemilu-
minescent dot-blotting assay (16). The immunoreactive material from
the column was pooled, dried by rotatory evaporation, resuspended in
water, and freeze-dried to remove traces of ammonium acetate. For the
material submitted to lipid analysis, the samples were further parti-
tioned between water and butan-1-ol to remove any remaining phos-
pholipid and/or glycolipid contaminants. The aqueous phase was
washed twice more with water-saturated butanol and freeze-dried
again.
Nitrous Acid Deamination and NaB3H4 Reduction of GPI Neutral
Glycans and Recovery of the Phosphatidylinositol Moieties—About 20
nmol of 35/50-kDa mucin of epimastigotes and metacyclic trypomastig-
otes, as judged by the myo-inositol content (see below) were freeze-
dried, resuspended in 50 ml of 0.3 M sodium acetate, pH 4.0, and washed
three times with 100 ml of butan-1-ol saturated with water. Then 25 ml
of 1 M sodium nitrite was added to the aqueous phase (two times at 1-h
intervals), and deamination was performed for 2 h at 37 °C. The re-
leased phosphatidylinositol (PI) moieties were recovered by three ex-
tractions with 100 ml of butan-1-ol saturated with water and analyzed
by electrospray-mass spectrometry (ES-MS), as described below. The
deaminated molecules remaining in the aqueous phase were reduced
with NaB3H4, as described in Ref. 22, and repurified by chromatogra-
phy on a Sephadex G-10 column, where they eluted in the void volume.
The deaminated and NaB3H4-reduced mucins were then dephosphoryl-
ated in 48% aqueous HF for 60 h at 0 °C and re-N-acetylated, and the
GPI neutral glycans were purified from radiochemical contaminants by
downward paper chromatography and high voltage paper electrophore-
sis (22). The 3H-labeled neutral glycans were analyzed by Bio-Gel P4
chromatography and Dionex high-performance anion-exchange chro-
matography. The elution positions of the radiolabeled glycans were
expressed in glucose units (Gu) and Dionex units, respectively, by linear
interpolation of the elution position between adjacent glucose oligomer
internal standards (22).
Microsequencing of the GPI Glycan Cores—Three aliquots (20,000
cpm) of the neutral glycan fractions recovered from the Bio-Gel P4
column were dried in speed-vac and subjected to digestion with jack
bean a-mannosidase (Boehringer Mannheim), Aspergillus saitoi
Mana1–2Man-specific a-mannosidase (Oxford Glycosystems) and by
partial acetolysis. Digestions were carried out with 0.75 units of jack
bean a-mannosidase in 30 ml of 0.1 M sodium acetate buffer, pH 5.0, for
16 h at 37 °C or with 0.01 units of A. saitoi a-mannosidase in 10 ml of 0.1
M sodium acetate buffer, pH 5.0, for 16 h at 37 °C. Acetolysis was
performed as described in Ref. 23. The products were analyzed by high
performance thin layer chromatography (HPTLC) on silica gel 60 plates
(Merck) using solvent A, propan-1-ol/acetone/water (9:6:4, by volume).
Radioactive glycans were detected with a radioactivity linear analyzer
(Raytest RITA) and visualized by fluorography after spraying with
En3Hance (DuPont NEN). A set of standards, terminating in [1-3H]2,5-
anhydromannitol (AHM*), was prepared by partial acid hydrolysis (23)
of authentic Mana1–2Mana1–2Mana1–6Mana1–4AHM*, prepared
from T. cruzi lipopeptidophosphoglycan (LPPG) (24). This so called
Man4 ladder contains a mixture of Mana1–2Mana1–2Mana1–
6Mana1–4AHM* (M4), Mana1–2Mana1–6Mana1–4AHM* (M3),
Mana1–6Mana1–4AHM* (M2), Mana1–4AHM* (M1), and AHM*.
Location of the Ethanolamine Phosphate and 2-Aminoethylphospho-
nate Groups—This method was adapted from Ref. 23. Deaminated and
NaB3H4-reduced mucins, 500,000 cpm (before dephosphorylation with
aqueous HF), were subjected to partial acid hydrolysis in 500 ml of 0.1
M trifluoroacetic acid (100 °C, 12 h). The samples were dried in a
speed-vac and redried twice from 200 ml of water. The hydrolysates
were then split into three portions and treated as follows: (i) dephos-
phorylated with aqueous HF (60 h, 0 °C), (ii) treated with jack bean
a-mannosidase prior to dephosphorylation with aqueous HF, or (iii)
passed directly through a 0.2-ml QAE-Sephadex A-25 column. The
products were analyzed by HPTLC using solvent A, as described above.
Mild Alkaline Treatment of 35/50-kDa Mucins and Fractionation of
Oligosaccharitols—About 200 nmol of metacyclic 35/50-kDa mucin was
freeze-dried twice, resuspended in 250 ml of 0.1 M NaOH containing 250
mM NaB2H4, and incubated for 24 h at 37 °C. The sample was acidified
with 1 M acetic acid, desalted by passage through 0.6 ml of AG 50-X12
(H1) (Bio-Rad), and dried, and boric acid was removed by co-evapora-
tion with 250 ml of 5% acetic acid in methanol (three times) and with
250 ml of methanol (three times). Residual acetic acid was removed by
co-evaporation with 50 ml of toluene (two times). Radiolabeled oligosac-
charitols were prepared from freeze-dried mucins resuspended in 15 ml
of 0.1 M of NaOH containing 36 mM NaB3H4 (13.6 Ci/mmol, DuPont
NEN) and incubated for 24 h at 37 °C, followed by desalting as de-
scribed above. Released radiolabeled oligosaccharitols were purified
from radiochemical contaminants by descending paper chromatography
on Whatman 3MM paper in butan-1-ol/ethanol/water (4:1:0.6, by vol-
ume) and digested with 50 mM Arthrobacter ureafaciens sialidase (Ox-
ford Glycosystems) in 25 ml of 50 mM sodium acetate (pH 5.0) for 20 h
at 37 °C. After desalting (as described below for the exoglycosidase
digests) the neutral oligosaccharitols were fractionated by HPLC using
a 5-mm hydrophilic interaction GlycoplexTM column (200 3 46 mm,
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PolyLC Inc.). Briefly, samples were dissolved in 80% acetonitrile, water,
and the column was eluted with an 80-ml gradient from 80 to 60%
acetonitrile in water, at 1 ml/min. In preparative experiments, some of
the radiolabeled material was added to the NaB2H4-reduced material to
act as a tracer.
Purified oligosaccharitols obtained by fractionation on the Glyco-
plexTM HPLC column were submitted to exoglycosidase digestion, as
described below, or to mild acid hydrolysis (200 ml of 40 mM trifluoro-
acetic acid for 1 h at 100 °C) to preferentially cleave Galf glycosidic
bonds (25), dried in a speed-vac, redried twice from 200 ml of water and
re-N-acetylated as described in Ref. 22. The products were analyzed by
Bio-Gel P4 chromatography.
Exoglycosidase Digestion—Neutral 3H-labeled oligosaccharitols were
analyzed before and after exoglycosidase digestion by HPTLC using
solvent B, butan-1-ol/acetone/water (6:5:4, by volume). Oligosacchari-
tols were digested with 0.75 units of coffee bean a-galactosidase (Boeh-
ringer Mannheim) in 30 ml of 0.1 M sodium citrate/phosphate buffer, pH
6.0, for 16 h at 37 °C, with 2.5 units of fresh bovine testicular b-galac-
tosidase (Boehringer Mannheim) in 20 ml of 0.1 M sodium citrate/
phosphate buffer, pH 4.5, for 16 h at 37 °C, or with 0.1 units of jack bean
b-galactosidase (Oxford Glycosystems) in 25 ml of 50 mM sodium acetate
buffer, pH 3.5, containing 38 mg/ml BSA, for 16 h at 37 °C. All reactions
were terminated by heating at 100 °C for 5 min. The products were
desalted by passage through a column of 0.2 ml of AG50X12 (H1), over
0.2 ml of AG3X4 (OH2) over 0.1 ml of QAE-Sephadex A-25. Eluates
were dried, and the residual acetic acid was removed by co-evaporation
with 50 ml of toluene (two times).
Compositional Analysis and Methylation Analysis—Amino acids,
ethanolamine, 2-aminoethylphosphonate, and glucosamine were quan-
tified after strong acid hydrolysis (6 M HCl, 110 °C, 16 h) and derivat-
ization with phenylisothiocyanate using a Waters Pico-Tag system, as
described (22). Gas chromatography-mass spectrometry (GC-MS) anal-
yses were performed with a Hewlett-Packard 5890-5970 system. The
myo-inositol content of samples was measured using selected ion mon-
itoring after strong acid hydrolysis and trimethylsilyl derivatization
(22). Monosaccharide and lipid contents were measured after metha-
nolysis, re-N-acetylation, and trimethylsilyl derivatization (22). Meth-
ylation linkage analysis was performed as described (22).
Electrospray-Mass Spectrometry—ES-MS data were obtained with a
VG-Quattro triple-quadrupole mass spectrometer (Fisons Instruments,
United Kingdom) coupled to a Michrom microbore HPLC system. Anal-
ysis of PI fractions was performed in negative ion mode, and aliquots of
PI samples (20 ml of PI dissolved in chloroform/methanol/water (10:
10:3, by volume)) were injected into the electrospray source at 5 ml/min.
Source and spectrometer parameters were optimized using a standard
of soybean PI (26). The masses of the released O-linked oligosaccharitol
components were determined in negative ion mode. Samples, dissolved
in 20 ml of 50% acetonitrile, were injected into the electrospray source
at 5 ml/min. Source and spectrometer conditions were optimized using a
standard of maltoheptaose (Sigma).
1H NMR—One-dimensional 500-MHz 1H NMR spectra of the indi-
vidual oligosaccharitols were obtained using a Bruker AM 500 spec-
trometer equipped with a 5-mm triple resonance probe, and the samples
were dissolved in 0.5 ml of 2H2O after repeated exchange in
2H2O. All
experiments were performed at 300 K, and chemical shifts were refer-
enced externally to acetone (2.225 ppm). Further assignments for oli-
gosaccharitol c were deduced from two-dimensional 1H-1H experiments.
Correlated spectroscopy and triple quantum-filtered correlated spec-
troscopy experiments were performed using a sweep width of 2,200 Hz,
and 4,000 data points, and 512 increments were collected in f1. The
rotating frame Overhauser effect spectroscopy experiment used 64
transients of 4,000 data points, and 1,024 increments were collected in
f1. The spectral width collected was 4,400 Hz in each domain, and the
mixing time was 500 ms. In the total correlation spectroscopy experi-
ment, 64 transients of 4,000 datapoints were collected, and 512 exper-
imental increments were collected in f1. The sweep width was 1,500 Hz,
and the mixing time used was 203 ms.
Trans-sialylation of Mucin O-Linked Oligosaccharitols—Purified ra-
diolabeled neutral oligosaccharitols, obtained after fractionation on the
GlycoplexTM HPLC column, were dried in a speed-vac and redissolved
in 0.02 M HEPES buffer (pH 7.0), 1 mM 39-sialyllactose (SAa2–3Galb1–
4Glc) (Boehringer Mannheim), 0.2% bovine serum albumin (Ultrapure,
Boehringer Mannheim) and incubated with purified T. cruzi TS (27).
After 2 h at 37 °C, the reaction was stopped by the addition of 1 ml of
water, and the amount of nonsialylated products was quantified by
passage through a 0.5-ml QAE-Sephadex A-25 column equilibrated in
water. Sialylated products were recovered after washing the column
with 8 ml of water and elution with 1 ml of 1 M ammonium formate.
Alternatively, the products were adjusted to 5 mM sodium acetate
buffer, pH 4.0, and chromatographed on a Mono Q column, as described
in Ref. 28, to determine the extent of sialylation of each individual
oligosaccharide.
RESULTS
The mucins were purified from epimastigotes and metacyclic
trypomastigotes by solvent extraction and octyl-Sepharose
chromatography. The material recognized by the monoclonal
antibody 10D8, specific for the sialic acid acceptors, eluted at
25% (v/v) propan-1-ol and appeared as two bands with appar-
ent molecular masses of 35 and 50 kDa on SDS-polyacrylamide
gel electrophoresis, as shown previously for the metacyclic try-
pomastigote sialic acid acceptors (12). The significance of the
double nature of the antigen is unknown, but it may reflect the
presence of at least two different (O-glycosylated/GPI-an-
chored) gene products. The purified mucins were judged to be
free of T. cruzi LPPG, which migrates near the front of an
SDS-polyacrylamide electrophoresis gel, by silver staining and
by Western blot analysis using an LPPG-specific antibody
(data not shown). Based on the myo-inositol content of the
recovered material (25 nmol/1010 cells), the metacyclic mucin is
present at a minimum of 1.5 3 106 copies/parasite. The mucins
eluted from the octyl-Sepharose column were subjected to com-
positional analysis, showing that amino acids (particularly Ser
and Thr) and monosaccharides (Man, Gal, GlcNAc, and SA)
together with myo-inositol, ethanolamine, 1-O-hexadecylglyc-
erol, and fatty acids were present in both preparations in
amounts similar to those reported previously (8, 12). In addi-
tion, a previously unidentified peak in the amino acid analyses
(with a retention time of 3.2 min) was shown to co-elute with an
authentic standard of 2-aminoethylphosphonate (2-AEP). The
molar ratio of ethanolamine to 2-AEP was approximately 1:1
for both preparations.
GPI Lipid Structure—The mucins (approximately 20 nmol of
each, based on myo-inositol content) were subjected to nitrous
acid deamination and extracted with butan-1-ol. The butan-
1-ol extracts, containing the released PI moieties, were ana-
lyzed by ES-MS. The mucin isolated from epimastigotes pro-
duced one major pseudomolecular ion at m/z 795.5 and minor
ions at m/z 809.6 and 823.6 (Fig. 1A). No other ions were
observed in the mass rangem/z 400-1400 (data not shown). The
collision-induced dissociation daughter ion spectra of the m/z
823 and 795 parent ions (Fig. 1, C and D), define the parent
ions as the [M-1]2 pseudomolecular ions of 1-O-(C16:0)alkyl-2-
O-(C18:0)acylglycerol-3-HPO4-inositol and 1-O-(C16:0)alkyl-2-O-
(C16:0)acylglycerol-3-HPO4-inositol, respectively. The common




2, respectively. The daughter ions at m/z 283




In contrast, the mucin from metacyclics showed, in addition
to the same alkylacyl-PI pseudomolecular ion species at m/z
795.5 and 823.6, abundant ions at m/z 892.7 and 780.6 (Fig.
1B). The daughter ion spectra of these species (Fig. 1, E and F)
define these ions as the [M-1]2 pseudomolecular ions of inositol
phosphoceramides (ceramide-PIs). In this case, the daughter






2, respectively. The relatively stable am-
ide bond of the ceramide prevents the formation of the carbox-
ylate ions seen previously for the alkylacyl-PI species. The m/z
values of the pseudomolecular ions at m/z 892.7 and 780.6
suggest that the ceramide components are made up of a sphin-
ganine (C18:0) long chain base and C24:0 and C16:0 fatty acids,
respectively. The minor pseudomolecular ions atm/z 890.7 and
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778.6 most likely represent ceramide-PIs containing sphingo-
sine (C18:1) or mono-unsaturated fatty acids. The collision-
induced daughter ion spectra of the m/z 795.5 and 823.6 ions
were identical to those shown in panels C and D (data not
shown). The relative proportions of all of different PI species
and the tentative identification of some of the very minor
species are given in Table I.
Structure of the GPI Glycan—To determine the structure of
the GPI glycans, the aqueous phase obtained after butan-1-ol
extraction of the deaminated mucins was reduced with NaB3H4
and dephosphorylated with aqueous HF, and the resulting GPI
neutral glycans were purified by paper chromatography and
high voltage paper electrophoresis. The neutral glycan frac-
tions were chromatographed by Dionex HPAEC and Bio-Gel P4
gel filtration (data not shown). The neutral glycans derived
from the epimastigotes and metacyclic trypomastigotes mucins
eluted as one major component on both systems with chromato-
graphic values of 3.0 Dionex units and 5.2 Gu, respectively.
These values are identical to those of authentic Mana1–
2Mana1–2Mana1–6Mana1–4AHM* (Man4-AHM*) (22). This
sequence was confirmed by exoglycosidase digestion and par-
tial acetolysis followed by product analysis by HPTLC (Fig. 2A).
For the neutral glycans derived from both mucins, digestion
with Mana1–2Man-specific A. saitoi a-mannosidase yielded a
major product that comigrated with Mana1–6Mana1–4AHM*
(Man2-AHM*) (Fig. 2A, lanes 2 and 6); partial acetolysis, which
selectively hydrolyzes Mana1–6Man glycosidic bonds, pro-
duced a major product that comigrated with Mana1–4AHM*
(Man1-AHM*) (Fig. 2A, lanes 3 and 7), and jack bean a-man-
nosidase, which removes all unsubstituted nonreducing termi-
nal aMan residues, produced a major product that comigrated
with AHM*. One additional minor neutral glycan structure,
with a slower mobility than Man4-AHM*, was also detected in
metacyclic and epimastigote preparations (Fig. 2A, lanes 1 and
5). This additional band can be seen more clearly in Fig. 2B,
which shows the results for the epimastigote neutral glycan
fraction before and after the sequencing digestions. This addi-
tional band was sensitive to A. saitoi a-mannosidase, producing
a faint band migrating between Man2-AHM* and Man3-AHM*
(Fig. 2B, lane 2), and digestion with jack bean a-mannosidase
produced, in addition to the AHM*, a product that migrated
slightly ahead of Man2-AHM* (Fig. 2B, lane 4). Thus, this
minor component probably represents a Man4-AHM* structure
with an additional, jack bean a-mannosidase-resistant residue
linked to the first aMan adjacent to the AHM* (i.e. Mana1–
2Mana1–2Mana1–6(X-)Mana1–4AHM*. Due to the low abun-
dance of this glycan, its structure was not studied further.
Location of the Phosphoryl/Phosphonyl Substituents in the
Glycan—Samples of the deaminated and NaB3H4-reduced epi-
mastigote and metacyclic mucins were subjected to partial acid
hydrolysis, using conditions that retain phosphoryl and phos-
phonyl substituents but partially cleave glycosidic bonds (23).
The hydrolysates were then split into aliquots and (i) dephos-
phorylated with aqueous HF, (ii) treated with jack bean a-man-
nosidase prior to dephosphorylation with aqueous HF, or (iii)
passed through a QAE-Sephadex A-25 ion exchange column.
The products of these treatments were analyzed by HPTLC
(Fig. 3). The dephosphorylated samples produced ladders of the
components Man4-AHM*, Man3-AHM*, Man2-AHM*, Man1-
AHM*, and AHM* (Fig. 3, lanes 2 and 6). In contrast, all of the
bands except for Man3-AHM* and AHM* were diminished in
the samples treated with mannosidase prior to dephosphoryl-
ation (Fig. 3, lanes 3 and 7). At least part of the less intense
bands, migrating below Man3-AHM* and above Man2-AHM*,
probably originated from the Mana1–2Mana1–2Mana1–6(X-)
Mana1–4AHM*-containing mucin species. This result indi-
cates that the Man3-AHM* component was fully protected
from a-mannosidase digestion by an aqueous HF-sensitive sub-
stituent attached to the third aMan residue distal to the
AHM*. This substituent is most likely an ethanolamine phos-
phate moiety, attached to the 6-position of the third aMan
residue, that is the conventional GPI anchor bridge to the
polypeptide chain (29). Another possibility is that part of this
aqueous HF-sensitive substituent is 2-aminoethylphospho-
nate, as described for the GPI of epimastigote mucin of Y strain
(17). Both ethanolamine and 2-aminoethylphosphonate were
identified in the compositional analyses of the epimastigote
and metacyclic trypomastigote mucins. When the partial acid
hydrolysis products were passed through QAE-Sephadex, most
of the Man4-AHM*, Man3-AHM*, Man2-AHM*, Man1-AHM*,
and AHM* radioactivity was lost, indicating that all of the GPI
glycans were negatively charged prior to dephosphorylation.
This, in turn, suggests that most of the AHM* residues were
originally substituted with phosphoryl (i.e. ethanolamine phos-
phate) and/or phosphonyl (i.e. 2-AEP) substituents, both of
FIG. 1. Negative ion electrospray mass spectra of the mucin PI
moieties. The PI moieties released from the epimastigote and metacy-
clic mucins (panels A and B, respectively) by nitrous acid deamination
were recovered by solvent extraction and analyzed by ES-MS. The
identities of major species detected in the epimastigote (panel A, m/z
823 and 795) and metacyclic (panel B, m/z 892 and 780) PI fractions
were corroborated by the collision-induced dissociation daughter ion
spectra (panels C and D and panels E and F, respectively).
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which have been found attached to the 6-position of the GlcN
residue of kinetoplastid GPI structures (29). The nature of the
intense radioactive bands running below the Man4-AHM*
band (Fig. 3, lanes 4 and 8) is unknown. However, these sam-
ples (unlike those in lanes 2, 3, 6, and 7) had not undergone
high voltage paper electrophoresis prior to analysis and may be
non-carbohydrate radiochemical contaminants. The deduced
structures of the GPI anchors for the epimastigote and meta-
cyclic trypomastigote mucin are shown in Fig. 4.
Structure of the O-Linked Oligosaccharides of the Epimastig-
ote and Metacyclic Trypomastigote Mucins—The O-linked oli-
gosaccharides were released by b-elimination in the presence of
NaB2H4 or NaB
3H4, desialylated with neuraminidase, and sep-
arated on a GlycoplexTM hydrophilic interaction HPLC column.
The column profiles revealed the presence of 6 major peaks
(peaks a–f) that were similar in both preparations (Fig. 5, A and
B). The purity of individual neutral oligosaccharides was as-
sessed by HPTLC (Fig. 5C). The migration on HPTLC followed
the separation in the GlycoplexTM column, except for oligosac-
charide b (identified as Galfb1–4GlcNAc-ol; see below), which
was found to migrate slightly ahead of fraction a (GlcNAc-ol).
The two minor fractions, labeled b9 and d9 were shown to
contain unique structures that have not been fully character-
ized in this study. The structures of the components of peaks
a–f are shown in Fig. 6. The experimental data supporting
these assignments are given below.
Peak a contained a component that produced an [M-1]2
pseudomolecular ion atm/z 223 in negative ion ES-MS and that
contained only [1-2H]GlcNAc-ol, as judged by GC-MS composi-
tion analysis (Table II). These data define peak a as the alditol
GlcNAc-ol.
Peak b contained a component that produced an [M-1]2
pseudomolecular ion at m/z 385 in negative ion ES-MS (deu-
tero-reduced Hex-HexNAc-ol 5 386 Da) and that contained
only [1-2H]GlcNAc-ol and Gal, as judged by GC-MS composi-
tion analysis (Table II). The GC-MS methylation analysis re-
vealed the presence of a terminal Galf residue and 4-O-substi-
tuted [1-2H]GlcNAc-ol (Table II). The radiolabeled (NaB3H4-
reduced) form of this component had a size of 3.5 Gu that was
reduced to 2.6 Gu (the size of HexNAc-ol) after cleavage of the
Galf residue by mild acid hydrolysis (Table IV). The chemical
shift (5.154 ppm; Table II) and extremely small J1,2 coupling
constant (data not shown), of the Galf H-1 proton defined the
galactofuranosidic linkage as b (8). Taken together, these data
define the peak b component as Galfb1–4GlcNAc-ol.
Peak c contained a component that produced an [M-1]2
pseudomolecular ion at m/z 547 in negative ion ES-MS (deu-
tero-reduced Hex2-HexNAc-ol 5 548 Da) and that contained
only [1-2H]GlcNAc-ol and Gal, as judged by GC-MS composi-
tion analysis (Table II). The GC-MS methylation analysis re-
TABLE I
Inositol-phospholipid composition of T. cruzi mucins
Lipid composition of 1-O-alkyl-2-O-acylglycerols [M-1]2 of the inositol-
phospholipid
Relative abundance of each speciesa
1-O-Alkylglycerol 2-O-Acyl fatty acid epi-Mucin meta-Mucin
m/z %
1-O-Hexadecylglycerol C16:0 795.5 91 24
1-O-Hexadecylglycerol C18:0 823.6 9 7
Lipid composition of ceramides [M-1]2 of the inositol-
phospholipid
Relative abundance of each species
Long chain base Amide-linked fatty acid epi-Mucin meta-Mucin
m/z %
C18 sphinganine C16:0 780.6 0 15
C18 sphinganine C18:0 808.6 0 4
C18 sphinganine C24:0 892.7 0 48
C18 sphinganine C26:0 920.7 0 2
a Estimated from the relative abundances of the [M-1]2 pseudomolecular ions.
FIG. 2. Sequential exoglycosidase digestion and partial acetol-
ysis of GPI neutral glycans. A, neutral glycans from epimastigotes
(EPI) and metacyclic trypomastigote (META) mucins were obtained by
nitrous acid deamination and reduction with NaB3H4, followed by aque-
ous HF treatment, and microsequenced by exoglycosidase digestion and
partial acetolysis as described under “Materials and Methods.” The
labeled glycans were analyzed by HPTLC in solvent system A without
treatment (lanes 1 and 5) or after A. saitoi a-mannosidase (lanes 2 and
6), partial acetolysis (Ac2O)(lanes 3 and 7) or jack bean a-mannosidase
(lanes 4 and 8) digestions. On the right side are indicated the migration
positions of Mana1–2Mana1–2Mana1–6Mana1–4AHM (Man4-
AHM*); Mana1–2Mana1–6Mana1–4AHM* (Man3-AHM*); Mana1–
6Mana1–4AHM* (Man2-AHM*); Mana1–4AHM* (Man1-AHM*); and
2,5-anhydromannitol (AHM*) standards obtained from T. cruzi LPPG.
DEX is 3H-reduced dextran hydrolysate standard. F corresponds to the
solvent front and OR to the origin. Panel B shows an additional HPTLC
of epimastigote neutral glycan, with a longer exposure time.
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vealed the presence of a terminal Galf residue, a terminal Galp
residue, and 4,6-di-O-substituted [1-2H]GlcNAc-ol. The radio-
labeled (NaB3H4-reduced) form of this component had a size of
4.5 Gu that was reduced to 3.5 Gu after cleavage of the Galf
residue by mild acid hydrolysis or after the cleavage of the
bGalp residue with jack bean b-galactosidase (Table IV). The
sensitivity of the structure to jack bean b-galactosidase, which
does not efficiently cleave Galpb1–4GlcNAc-ol, and its resist-
ance to bovine testicular b-galactosidase, which does cleave
Galpb1–4GlcNAc-ol (16), suggest that the bGalp residue is
attached to the 6-position of the GlcNAc-ol residue and that the
peak c component has the structure Galpb1–6(Galfb1–4)Glc-
NAc-ol. The chemical shifts of the protons of this component
(Table III), which are identical to those described in (8) for the
same structure, confirm this assignment. The data in Table III
add some additional assignments compared with Ref. 8: (i) the
H-5 resonance of the bGalp residue, which was assigned by
chemical shift arguments in Ref. 8, was confirmed from the
rotating frame Overhauser effect spectroscopy experiment, and
(ii) the H-69 proton of the bGalf residue was assigned via the
triple quantum-filtered correlated spectroscopy experiment,
which is selective for the H-5, H-6, and H-69 protons.
Peak d contained a component that produced an [M-1]2
pseudomolecular ion at m/z 709 in negative-ion ES-MS (deu-
tero-reduced Hex3-HexNAc-ol 5 710 Da) and that contained
only [1-2H]GlcNAc-ol and Gal, as judged by GC-MS composi-
tion analysis (Table II). The GC-MS methylation analysis re-
vealed the presence of a terminal Galf residue, a terminal Galp
residue, a 3-O-substituted Galp residue, and 4,6-di-O-substi-
FIG. 3. Location of phosphoryl/phosphonyl substituents.
HPTLC analysis of the mucins subjected to partial acid hydrolysis
followed by sequential exoglycosidase digestion and dephosphorylation.
Deaminated and reduced mucins from epimastigotes (EPI) and meta-
cyclic trypomastigote (META) mucins were subjected to partial acid
hydrolysis (H1) followed by aqueous HF dephoshorylation (HF) (lanes 2
and 6), partial acid hydrolysis, jack bean a-mannosidase digestion, and
aqueous HF dephosphorylation (lanes 3 and 7) or to partial acid hydrol-
ysis and passage through QAE-Sephadex A-25 column (lanes 4 and 8).
The products were analyzed by HPTLC in solvent A and fluorography.
The migration of standards (DEX), and the glycans of T. cruzi LPPG (as
described in Fig. 2) are shown in lanes 1 and 5.
FIG. 4. Proposed GPI anchor structures of T. cruzimucins. See
text for details.
FIG. 5. Fractionation of mucin oligosaccharitols released by
reductive b-elimination. Epimastigote (panel A) and metacyclic try-
pomastigote (panel B) mucins were submitted to mild alkaline b-elim-
ination, with concomitant reduction with NaB3H4, and separated by
HPLC using a GlycoplexTM column, as described under “Materials and
Methods.” C, the purity of individual oligosaccharitols from metacyclic
sample (lanes a–f) versus the unfractionated oligosaccharitol mixture
(lane T) was accessed by HPTLC in solvent system B. Lane S contains
a [1-3H]GlcNAc-ol standard, and lane DEX contains the 3H-reduced
dextran hydrolysate standard.
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tuted [1-2H]GlcNAc-ol. The radiolabeled (NaB3H4-reduced)
form of this component had a size of 5.6 Gu that was reduced to
4.5 Gu after cleavage of the Galf residue by mild acid hydrolysis
and to 3.5 Gu after the cleavage of 2 bGalp residues with jack
bean b-galactosidase (Table IV). Taking into account the meth-
ylation data, the accessibility of both bGalp residues to jack
bean b-galactosidase suggests that they are linked together in
the form Galpb1–3Galb1-. The bovine testicular b-galactosid-
ase enzyme was capable of removing the terminal b1–3-linked
Gal residue only, to yield a 4.5-Gu product, again suggesting
that the bGalp branch was attached to the 6-position of the
GlcNAc-ol residue. Taken together, these data suggest that the
peak d component has the structure Galpb1–3Galpb1–
6(Galfb1–4)GlcNAc-ol. The chemical shifts of the anomeric
protons of this component (Table II), which are identical to
those described in Ref. 8 for the same structure, confirm this
assignment.
Peak e contained a component that produced an [M-1]2
pseudomolecular ion at m/z 871 in negative ion ES-MS (deu-
tero-reduced Hex4-HexNAc-ol 5 872 Da) and which contained
only [1-2H]GlcNAc-ol and Gal, as judged by GC-MS composi-
tion analysis (Table II). The GC-MS methylation analysis re-
vealed the presence of a terminal Galf residue, two terminal
Galp residues, a 2,3-di-O-substituted Galp residue, and 4,6-di-
O-substituted [1-2H]GlcNAc-ol. The radiolabeled (NaB3H4-re-
duced) form of this component had a size of 6.4 Gu that was
reduced to 5.4 Gu after cleavage of the Galf residue by mild acid
hydrolysis (Table IV). Interestingly, the structure was resist-
ant to both jack bean b-galactosidase and bovine testicular
b-galactosidase enzymes.2 The chemical shifts of the anomeric
protons of this component (Table II) are identical to those
described in Ref. 8 for the structure Galpb1–3(Galpb1–
2)Galpb1–6(Galfb1–4)GlcNAc-ol, and all of the above data are
consistent with this structure.
Peak f contained a component that produced an [M-1]2
pseudomolecular ion at m/z 1,033 in negative ion ES-MS (deu-
tero-reduced Hex4-HexNAc-ol 5 1,034 Da) and that contained
only [1-2H]GlcNAc-ol and Gal, as judged by GC-MS composi-
tion analysis (Table II). The radiolabeled (NaB3H4-reduced)
form of this component had a size of 7.1 Gu that was reduced to
5.5 Gu after mild acid hydrolysis, suggesting that the structure
contained either 2 Galf residues or 1 Galf residue that is sub-
stituted by a Galp residue (Table IV). The structure was resist-
ant to both jack bean b-galactosidase and bovine testicular
b-galactosidase enzymes.2 The chemical shifts of the anomeric
protons of this component (Table II) are identical to those
described in Ref. 8 for the structure Galpb1–3(Galpb1–
2)Galpb1–6(Galpb1–2Galfb1–4)GlcNAc-ol, and all of the
above data are consistent with this structure.
trans-Sialidase Acceptor Activity of the O-Linked Oligosac-
charides—Neuraminidase-treated, HPLC-purified, and radio-
labeled oligosaccharitols were incubated with purified TS and
39-sialyllactose as sialic acid donor, and the reaction products
were fractionated by QAE-Sephadex chromatography. As ex-
pected, all of the oligosaccharitols containing terminal bGalp
2 A number of useful details about the substrate specificities of jack
bean b-galactosidase and bovine testes b-galactosidase can be deduced
from this study: (i) neither enzyme can digest an oligosaccharide ter-
minating in Galpb1–3(Galpb1–2)bGalp; (ii) neither enzyme can digest
an oligosaccharide terminating in Galpb1–2bGalf; and (iii) bovine tes-
tes b-galactosidase cannot digest Galpb1–6GlcNAc-ol.
FIG. 6. Proposed structures of the O-linked oligosaccharitols
released from epimastigote and metacyclic trypomastigote mu-
cins. The structures were deduced as described in the text, except that
the sialylation patterns are inferred from the SA transfer experiments
described in Fig. 7. The relative percentage of each structure was based
on the recovery of each peak relative to the labeled material as shown
in Fig. 5.
TABLE II




1H NMR chemicalc shifts Methylation analysisd




b 385 5.154 1 2 1 2 2 2
(Hex-HexNAc-ol)
c 547 5.215 4.432 2 1 1 1 2 2
(Hex2-HexNAc-ol)
d 709 5.217 4.493 4.613 2 1 1 1 1 2
(Hex3-HexNAc-ol)
e 871 5.273 4.582 4.662 4.862 2 1 1 11e 2 1
(Hex4-HexNAc-ol)
f 1033 5.534 4.642 4.656 4.850 4.603 NDf
(Hex5-HexNAc-ol)
a Components contained GlcNAc-ol (a–f) and Gal (b–f) by GC-MS compositional analysis.
b [M-1]2 pseudomolecular ions detected by negative-ion ES-MS.
c Data obtained from one-dimensional 500-MHz NMR spectroscopy. Chemical shifts were referenced relative to acetone (2.225 ppm.) at 300 K.
d Obtained from analysis of partially methylated alditols acetate (PMAAs).
e Two terminal Galp residues detected.
f Not determined.
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were sialylated, while the oligosaccharitol b, which contains
only a terminal bGalf residue, was not a sialic acid acceptor
(not shown). To further evaluate the degree of sialylation of
oligosaccharitols c–f, the TS reaction products were fraction-
ated in a Mono-Q column. Oligosaccharitols c and d, which
contain single bGalp termini, accepted only one sialic acid
residue, as expected (Fig. 7, A and B). Oligosaccharitol e, which
contains two terminal bGalp residues (attached to the 2- and
3-position of the same subterminal residue) accepted only one
sialic acid residue (Fig. 7C). This result indicates that either
only one of the terminal bGalp residues can be sialylated or
sialylation of either residue precludes sialylation of the adja-
cent residue for steric reasons. Oligosaccharitol f, which, com-
pared with oligosaccharitol e, has one additional bGalp at-
tached to a different branch, was both monosialylated and
bisialylated (Fig. 7D). These sialylation patterns are included
in Fig. 6.
DISCUSSION
We have compared the structures of the O-linked oligosac-
charides and the GPI anchors of the major mucin-like SA
acceptors from metacyclic trypomastigote and epimastigote
forms of T. cruzi. We found that when epimastigotes transform
into metacyclic trypomastigotes the O-linked oligosaccharides
and the GPI glycan core structures remain unchanged,
whereas the lipid portion of the GPI anchor changes substan-
tially from alkylacylglycerol-PI to mostly ceramide-PI. The
ES-MS analyses showed that the epimastigote mucins contain
alkylacyl-PI species, the principal component being 1-O-hexa-
decyl-2-O-hexadecanoyl-PI, whereas 70% of the metacyclic mu-
cins contain inositol phosphoceramides (ceramide-PIs), with
the principal ceramide components identified as lignoceroyl-
sphinganine and palmitoyl-sphinganine. The remaining 30% of
the metacyclic mucins contain the same alkylacyl-PI species as
the epimastigote mucins. The lipids present in the epimastig-
ote mucins of strain Y, identified as 40/45-kDa glycoconjugates,
were also shown to contain 1-O-hexadecyl-2-O-palmitoylglyc-
erol and 1-O-hexadecyl-2-O-stearoylglycerol (17), in similar
proportions to those found in G-strain epimastigotes in this
study. The lipid portion of a molecule called lipophosphoglycan-
like glycoconjugate, isolated from T. cruzi epimastigotes (Peru
strain) also contains the same alkylacylglycerol-PI species (9).
No direct evidence for the presence of phosphosaccharide re-
peats, characteristic of Leishmania lipophosphoglycans, was
presented in that study, and, given its similarity in composition
and properties to the mucin-like molecules reported here and in
Refs. 8, 12, 16, and 17, it should be considered as a member of
the T. cruzi mucin family.
The GPI anchors of both trypomastigote Tc-85 (30) and the
metacyclic 90-kDa 1G7-antigen (26, 31) have been shown to
contain mostly 1-O-hexadecyl-2-acyl-PIs, which are similar to
those reported here and in Refs. 9 and 17 for the epimastigote
mucin GPI membrane anchors. In the case of the metacyclic
mucins, the GPI anchor ceramide-PI structures are identical to
the main types found in LPPG, the major surface glycoconju-
gate of T. cruzi (Y strain) epimastigotes (32, 33); i.e. they
contain palmitoyl-sphinganine and lignoceroyl-sphinganine.
The LPPG molecule also shares the same Man4-GlcN core
glycan structure as the mucin GPI anchor and contains a
2-AEP group attached to the 6-position of the GlcN residue (24,
32, 33). Thus, it is possible that these ceramide-PI anchors are
biosynthetically related to LPPG. The putative point of biosyn-
thetic divergence would be in the addition of the ethanolamine
phosphate (or 2-AEP) bridge to Man4-(2-AEP)GlcN-(ceramide-
PI) to form the GPI anchor precursor or the addition of two
terminal Galf residues to form LPPG. The relationship between
the ceramide-PI type GPI structures and the alkylacyl-PI
structures is not clear. In the case of Saccharomyces cerevisiae,
the GPI precursors are based on diacyl-PIs that on most (but
not all) glycoproteins are exchanged to ceramide-PIs after
transfer to protein in an as yet undefined lipid-remodelling
reaction (34, 35). It is possible that a similar mechanism may
operate in T. cruzi, as discussed in Ref. 26. The observation
that all of the early GPI intermediates in T. cruzi epimastigotes
are based on alkylacyl-PI is consistent with this notion (36).
Interestingly, a glycoinositolphospholipid (called GIPL A) with
the same glycan core structure as LPPG, but containing a lipid
FIG. 7. Sialylation of O-linked oligosaccharitols of metacyclic
trypomastigote mucin accessed by Mono Q chromatography.
Purified and labeled neutral oligosaccharitols c–f (panels A, B, C, andD)
of metacyclic trypomastigotes were incubated with TS and sialyllactose,
as described under “Materials and Methods.” After 3 h of incubation,
the samples were diluted with 5 mM sodium acetate, pH 4.0, and loaded
onto a Mono Q column. The number above each peak represents the
amount of sialic acid residues per oligosaccharitol.
TABLE III
1H NMR chemical shifts of oligosaccharitol c
Proton bGalf bGalp GlcNAc-ol
H-1 5.21 4.43 3.73
H-19 3.66
H-2 4.14 3.56 4.17
H-3 4.08 3.66 3.93
H-4 4.09 3.92 3.82
H-5 3.82 3.71 4.03
H-6 3.63 3.76 4.14
H-69 3.72 3.78 3.84
NAc 2.06
TABLE IV
Bio-Gel P4 analysis of neutral O-linked carbohydrates of mucins from
metacylic trypomastigotes
Individual O-linked carbohydrates separated on HPLC, were chro-
matographed on a Bio-Gel P4 column, and the elution position relative
to a series of dextran oligomers was expressed as glucose units (Gu).
The oligosaccharides were further treated with bovine testicular b-ga-





a 2.6 NTa NT NT
b 3.5 —c — 2.6
c 4.5 — 3.5 3.5
d 5.6 4.5 3.5 4.5
e 6.4 — — 5.4
f 7.1 — — 5.5b
a NT, not treated.
b TFA treatment produced products correspondent to 7.0 and 5.5 Gu.
c No modification after treatment.
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moiety composed exclusively of 1-O-hexadecyl-2-O-palmitoyl-
glycerol, has been detected in early cultures of Y strain T. cruzi
epimastigotes (37). This glycoinositolphospholipid could be the
immediate precursor to LPPG. If so, the shift from alkylacyl-PI
to ceramide-PI seen in the mucins upon transformation of late
epimastigotes to metacyclic trypomastigotes may be similar to
the shift from GIPL A to LPPG seen upon the transformation
from early to late epimastigotes. Thus the change in the PI
lipid structure of the mucin molecules of T. cruzi appears to be
under developmental control. Interestingly, the ES-MS analy-
sis of the metacyclic 1G7-antigen PI moieties also revealed that
a small quantity (.15 mol %) of the GPI anchors contained
ceramide-PIs (26). However, in this case the ceramides were
predominantly palmitoyl-sphinganine and stearoyl-sphinga-
nine, and the reason for the lack of lignoceroyl-sphinganine is
not clear. As Grace’s medium was used to induce metacyclo-
genesis in the 1G7-antigen work, whereas liver infusion tryp-
tose medium was used throughout this mucin study, it is pos-
sible that the nutrient conditions might affect the fatty acid
content of the ceramide components.
The possibility that the ceramide-PI content of the metacy-
clic trypomastigote mucin preparation might be due to contam-
ination with LPPG can be ruled out for the following reasons:
(i) the mucin fractions were eluted from the octyl-Sepharose
column between 23 and 27% propan-1-ol, while LPPG is known
to elute from this column at .40% propan-1-ol (33); (ii) meta-
cyclic trypomastigotes express about 10 times less LPPG than
epimastigotes (38), suggesting that any LPPG contamination
would be greater in epimastigote preparations; (iii) no LPPG
could be detected in the mucin preparations by SDS-polyacryl-
amide gel electrophoresis and silver staining and by Western
blot with an anti-LPPG antibody; (iv) the mucin samples were
exhaustively pre-extracted with butan-1-ol to remove glycolipid
and phospholipid contaminants prior to deamination; (v) the
Man3-AHM* fragment, generated by partial acid hydrolysis of
the deaminated NaB3H4-reduced mucin, was completely pro-
tected from jack bean a-mannosidase digestion by an aqueous
HF-sensitive substituent (Fig. 3, lane 7). The corresponding
LPPG Man3-AHM* fragment would be digested to AHM*.
The structure of the major GPI glycan (shown to be as
Mana1–2Mana1–2Mana1–6Mana1–4GlcN-myo-inositol) was
identical in epimastigote and metacyclic mucins. A small pro-
portion of the GPI glycans contained an additional unidentified
sugar residue attached to the aMan residue adjacent to the
GlcN residue. Similar results have been reported recently for
the epimastigote mucin of Y strain (17). The major Man4 GPI
glycan structure described above is also found in the 1G7-
antigen (26), and this structure represents only a minor sub-
stitution of the conserved Man3 GPI glycan found in all GPI
anchors characterized to date (29). Interestingly, the GPI gly-
can core of one surface glycoprotein of infective trypomastigotes
derived from mammalian cells contained a glycan core com-
posed a Man3-GlcN rather than a Man4-GlcN (30).
The mucins from epimastigotes and metacyclic trypomasti-
gotes also share the same O-linked oligosaccharide chains,
linked to the protein backbone via N-acetylglucosamine resi-
dues rather than N-acetylgalactosamine that is commonly
found in vertebrate mucins. In the case of T. cruzi mucins
described here about 20% of the oligosaccharitols released by
reductive b-elimination corresponded to non-substituted Glc-
NAc-ol. Most of the O-linked GlcNAc residues are substituted
and might not be accessible. These substitutions included
chains formed by one to five additional galactose residues,
always with one bGalf residue linked to the 4-position of the
GlcNAc. The remaining bGalp residues are mostly linked as
linear and branched side-chains to the 6-position of the Glc-
NAc. The O-linked oligosaccharide structures determined in
this study are identical to those found in the epimastigote
mucin of G strain (8), except that the Galfb1–4GlcNAc-ol struc-
ture was not described by these authors. Since Galpb1–6Glc-
NAc-ol was not observed in this or any other study, we suggest
that during biosynthesis the addition of the bGalf residue
precedes the addition of the bGalp residues.
Studies of TS specificity have shown that the enzyme is able
to sialylate unbranched terminal bGalp residues, and that
substitutions near the Gal decrease the extent of sialylation
(39, 40). We have confirmed these findings by using the puri-
fiedO-linked oligosaccharides that are the natural acceptors on
the parasite surface. The branched oligosaccharide e, that has
two terminal bGalp residues, can accept only one SA, while the
oligosaccharide f, that has one additional terminal bGalp res-
idue, can accept a second SA. In agreement with these data, a
maximum of two SA are incorporated per oligosaccharide in
vivo (data not shown). The reasons why the branched oligosac-
charide structure cannot accept two SA residues is unknown,
but it is likely to be due to steric effects since the two terminal
bGalp residues are attached to adjacent oxygen atoms on the
penultimate Gal residue.
In summary, the major difference between epimastigote and
metacyclic mucins is the acquisition of a high content of cer-
amide-PI in the metacyclic forms, in the place of alkylacyl-PI.
Epimastigotes express large amounts of LPPG, which contains
the same ceramide-PI species, indicating that acquisition of
ceramide-PI in the mucin is not unique to metacyclic forms.
The reason why the metacyclic mucins are anchored to the cell
surface by a ceramide-PI, rather than an alkylacyl-PI, is un-
known. However, it may be significant that the majority of the
metacyclic mucins are shed by the parasite during host cell
invasion, whereas the majority of the alkylacyl-PI anchored
1G7-antigen is retained on the parasite surface (12). Thus,
surface-stability during invasion may be modulated by lipid
remodelling of specific molecules. The structural changes in the
mucin molecules upon metacyclogenesis are clearly less pro-
found than those observed in the LPGs of the Leishmania,
where the lipids remain unchanged but the type and/or number
of phosphosaccharide repeats change dramatically (41, 42).
Nevertheless, the mucin shedding phenomenon may make the
subtle change in lipid structure equally important for the in-
fectivity of T. cruzi.
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